Jaya Ranjalkar

India's National Action Plan for antimicrobial resistance – An overview of the context, status, and way ahead

S. Chandy, Jaya Ranjalkar, 2019, Journal of family medicine and primary care.

Isoniazid and rifampicin concentrations in children with tuberculosis with either a daily or intermittent regimen: implications for the revised RNTCP 2012 doses in India.

A. Bose, B. Mathew, V. Verghese, 2017, International journal of antimicrobial agents.

Challenges in Implementing Antimicrobial Stewardship Programmes at Secondary Level Hospitals in India: An Exploratory Study

S. Chandy, P. Mathew, Jaya Ranjalkar, 2020, Frontiers in Public Health.

Collateral effects and ethical challenges in healthcare due to COVID-19 – A dire need to support healthcare workers and systems

S. Chandy, Jaya Ranjalkar, S. Chandy, 2021, Journal of family medicine and primary care.

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India

J. Tarning, A. Bose, R. Hoglund, 2019, British journal of clinical pharmacology.

Evaluation of Efficacy of Tutorials in Pharmacology for 2nd year undergraduate Medical Students in India

Aniket Kumar, Deepasree Sukumaran, Sumalya Sen, 2016 .

Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

K. Taxis, R. Lodha, S. Kabra, 2022, European Respiratory Journal.

Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India

S. Chandy, Nilima Kshirsagar, A. Prakash, 2024, Indian journal of pharmacology.